Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02268370
Title Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)
Acronym TRAD
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Center Calgary Alberta Canada Details
University of Alberta Hospital Edmonton Alberta Canada Details
Vancouver General Hospital Vancouver British Columbia V5Z1M9 Canada Details
Cancer Care Manitoba Winnipeg Manitoba Canada Details
Queen Elizabeth II Health Sciences Centre Halifax Nova Scotia Canada Details
Juravinski Cancer Centre Hamilton Ontario Canada Details
London Health Sciences Centre London Ontario Canada Details
Ottawa General Hospital Ottawa Ontario Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Centre Hôpitallier Universitaire de Quebec - Hôpital de l'Enfant-Jésus Charlesbourg Quebec Canada Details
Hopital Maisonneuve-Rosemont Montreal Quebec Canada Details
McGill University Health Centre Montreal Quebec Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field